Riyadh – Mubasher: Al Razi Medical Company has been trading down 3.1% at SAR 29.34 during the Saudi session on 22 July 2026, placing the stock among the top losers in the retail sector.
The price movement follows recent corporate disclosures, including the opening of the nomination period for board of directors' membership and the announcement of results from the company’s Extraordinary General Assembly Meeting (EGM).
Technical indicators show the stock is trading below its key moving averages, with the 20-day Simple Moving Average (SMA) at SAR 30.89, the 50-day SMA at SAR 30.63, and the 200-day SMA at SAR 31.76.
The Relative Strength Index (RSI) is currently at 42.66, while the Moving Average Convergence Divergence (MACD) stands at 0.088.
The Average Directional Index (ADX) is recorded at 28.59, indicating a moderate trend strength.
The decline occurs as the company transitions through administrative updates following its recent shareholder meeting and the invitation for new board members.
